Ghassan K. Abou-Alfa, MD, reports on data results from the ClarIDHy trial.

Discussion Board › Forums › Chemotherapy & More › Ghassan K. Abou-Alfa, MD, reports on data results from the ClarIDHy trial.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • June 29, 2021 at 10:28 pm #101140
    gavin
    Moderator

    Ghassan K. Abou-Alfa, MD, reports on data presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting regarding final results from the ClarIDHy trial. In the phase 3 study, investigators examined ivosidenib vs placebo in patients with previously treated cholangiocarcinoma and an isocitrate dehydrogenase 1 mutation.

    https://www.onclive.com/view/final-results-from-phase-3-claridhy-trial

    The above link contains a video as well.

    Thanks,

    Gavin

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Chemotherapy & More’ is closed to new topics and replies.